Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep
Clinical trial NCT03575104 · COMPLETED
Trial details
- NCT number
- NCT03575104
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-29
- Primary completion
- 2020-04-09
- Enrollment
- 924
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.